Published in South Med J on November 01, 1980
Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med (1993) 4.72
Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis (1997) 3.29
Species identification of coagulase-negative staphylococci from urinary tract isolates. J Clin Microbiol (1978) 2.67
Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol (1997) 1.82
Enterobacter cloacae: bacteremia, epidemiology, and antibiotic resistance. Rev Infect Dis (1982) 1.80
Distribution of methicillin-resistant Staphylococcus aureus clones among health care facilities in Connecticut, New Jersey, and Pennsylvania. . Microb Drug Resist (2000) 1.57
Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance. J Infect Dis (1986) 1.55
Characteristics of Serratia marcescens containing a plasmid coding for gentamicin resistance in nosocomial infections. J Infect Dis (1981) 1.45
Evidence for a chromosomal site specifying amikacin resistance in multiresistant Serratia marcescens. Antimicrob Agents Chemother (1982) 1.44
Immunoblots, antimicrobial resistance, and bacteriophage typing of oxacillin-resistant Staphylococcus aureus. J Clin Microbiol (1988) 1.44
Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance. Am J Dis Child (1985) 1.29
Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome. Antimicrob Agents Chemother (1993) 1.26
Pseudobacteremia. Infect Control (1984) 1.25
Plasmids as epidemiologic markers in nosocomial gram-negative bacilli: experience at a university and review of the literature. Rev Infect Dis (1986) 1.23
Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group. J Infect Dis (1996) 1.21
Cefotaxime therapy. Evaluation of its effect on bacterial meningitis, CSF drug levels, and bactericidal activity. Arch Intern Med (1983) 1.15
Bactericidal action of modulated ultraviolet light on six groups of Salmonella. Infect Control Hosp Epidemiol (1991) 1.08
Dissemination of trimethoprim-resistant clones of Shigella sonnei in Bulgaria. J Infect Dis (1989) 1.06
Spinal syphilis: the problem of fluorescent treponemal antibody in the cerebrospinal fluid. South Med J (1977) 1.03
Topoisomerase sequences of coagulase-negative staphylococcal isolates resistant to ciprofloxacin or trovafloxacin. Antimicrob Agents Chemother (1999) 1.00
Activity of cephalosporins against methicillin-susceptible and methicillin-resistant, coagulase-negative staphylococci: minimal effect of beta-lactamase. Antimicrob Agents Chemother (1980) 0.99
Antibiotic cycling: is it ready for prime time? Infect Control Hosp Epidemiol (2000) 0.98
Relatedness of strains of methicillin-resistant coagulase-negative Staphylococcus colonizing hospital personnel and producing bacteremias in a neonatal intensive care unit. Pediatr Infect Dis J (1992) 0.97
Endemic Serratia marcescens infection in a neonatal intensive care nursery associated with gastrointestinal colonization. Pediatr Infect Dis (1985) 0.96
A sequence variant of Staphylococcus hominis with a high prevalence of oxacillin and fluoroquinolone resistance. Res Microbiol (2001) 0.95
Nephelometric detection of soluble immune complexes: methodology and clinical applications. Int Arch Allergy Appl Immunol (1979) 0.95
Trimethoprim-sulfamethoxazole therapy of pulmonary melioidosis. Am Rev Respir Dis (1976) 0.94
Effect of peritoneal dialysis solution on the antimicrobial activity of cephalosporins. Nephron (1982) 0.94
Epidemic methicillin-gentamicin-resistant Staphylococcus aureus in a neonatal intensive care unit. Am J Dis Child (1989) 0.93
Aminoglycoside resistance in Pseudomonas aeruginosa isolated from cystic fibrosis patients. Am J Clin Pathol (1984) 0.92
Molecular epidemiology of sequential nursery epidemics caused by multiresistant Klebsiella pneumoniae. J Pediatr (1983) 0.91
Sequence analysis of dru regions from methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococcal isolates. Microb Drug Resist (2001) 0.90
Methicillin-resistant Staphylococcus aureus outbreak at a Veterans' Affairs Medical Center: importance of carriage of the organism by hospital personnel. Infect Control Hosp Epidemiol (1990) 0.89
Characteristics of gentamicin resistance in nosocomial infections. Am J Med Sci (1980) 0.88
Topoisomerase mutations in trovafloxacin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1998) 0.88
Emergence of drug resistance mutations in a group of HIV-infected children taking nelfinavir-containing regimens. AIDS Res Hum Retroviruses (2001) 0.87
Molecular epidemiology of trimethoprim-resistant Shigella boydii serotype 2 strains from Bulgaria. J Clin Microbiol (1992) 0.86
Effect of the HIV-1 syncytium-inducing phenotype on disease stage in vertically-infected children. J Med Virol (1998) 0.86
In vivo R-plasmid transfer in a patient with a mixed infection of shigella dysentery. Epidemiol Infect (1994) 0.86
Smoking, the soldier, and the army. Mil Med (1977) 0.85
An outbreak of Pseudomonas cepacia bacteremia associated with a contaminated intra-aortic balloon pump. J Thorac Cardiovasc Surg (1988) 0.85
Increased frequency of large R-plasmids in Klebsiella pneumoniae colonizing patients with spinal cord injury. Diagn Microbiol Infect Dis (1993) 0.83
Tuberculous arachnoiditis. J Pediatr (1975) 0.82
Amifloxacin activity against well-defined gentamicin-resistant, gram-negative bacteria. Antimicrob Agents Chemother (1984) 0.81
Effect of inline filtration on postinfusion phlebitis. Clin Pharm (1983) 0.80
Mycobacterium fortuitum pulmonary infection associated with an antigen-selective defect in cellular immunity. Am J Med (1981) 0.79
Effect of formulary restriction of cefotaxime usage. Arch Intern Med (1985) 0.78
Cost-effective antimicrobial therapy: an approach for physicians and community hospitals. J S C Med Assoc (1986) 0.78
Case report 89. Skeletal Radiol (1979) 0.77
Cytomegalovirus pneumonia in sickle cell disease. Chest (1984) 0.77
Endocarditis associated with disseminated group B streptococcal infection. Am J Med Sci (1978) 0.77
Gonococcal endocarditis. Sex Transm Dis (1978) 0.77
Protected transbronchial needle aspiration and protected specimen brush in the diagnosis of pneumonia. Am Rev Respir Dis (1987) 0.76
HIV-1 reverse transcriptase mutations found in a drug-experienced patient confer reduced susceptibility to multiple nucleoside reverse transcriptase inhibitors. Antivir Ther (2001) 0.76
Respiratory syncytial virus infection in a cardiac surgery intensive care unit. J Thorac Cardiovasc Surg (1994) 0.76
Fenoprofen (Nalfon) overdose. Drug Intell Clin Pharm (1981) 0.76
Gram stain. Ann Intern Med (1998) 0.75
Enterobacter plasmids: molecular epidemiology. Infect Control Hosp Epidemiol (1995) 0.75
Risk factors associated with the acquisition of amikacin-resistant gram-negative bacilli in central New Jersey hospitals. Infect Control Hosp Epidemiol (1998) 0.75
Cefotaxime therapy of serious bacterial infection in adults. Antimicrob Agents Chemother (1982) 0.75
MRSA colonization. Infect Control (1987) 0.75
Isomeric DNA ladder formation of a plasmid encoding tobramycin resistance from Escherichia coli. J Antimicrob Chemother (1991) 0.75
Quinidine-nifedipine interaction. Drug Intell Clin Pharm (1985) 0.75
Low-dose streptokinase therapy for subclavian vein thrombosis. South Med J (1984) 0.75
Reducing lost drug charges by monitoring computer-generated interdepartmental transfers. Am J Hosp Pharm (1983) 0.75
Polyarteritis overlap syndrome with extensive bowel infarction. Am J Gastroenterol (1980) 0.75
Mass in tuberculous peritonitis. Ann Intern Med (1973) 0.75
Nerve conduction studies in natural rubella. Ann Neurol (1977) 0.75
Effect of periocularly administered gentamicin on serum aminoglycoside concentrations. Clin Pharm (1986) 0.75
Trimethoprim-sulfamethoxzole: a rational antibiotic combination with many potential indications. J S C Med Assoc (1976) 0.75
Miss Elsie Beale--old and alone. Midwife Health Visit (1969) 0.75
Using reprint requests to update a drug information file. Am J Hosp Pharm (1983) 0.75
Old problems with new names. JAMA (1982) 0.75
Gangrene of the tongue. Arch Intern Med (1994) 0.75
Nosocomial infection rates at a General Army Hospital. Am J Surg (1977) 0.75
Continuing a clinical pharmacokinetic dosing service under prospective pricing. Am J Hosp Pharm (1985) 0.75
Suspected metronidazole hepatotoxicity. Clin Pharm (1983) 0.75
Kinetic dosing computer support. Drug Intell Clin Pharm (1985) 0.75